Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000902664-25-002745·ADC Therapeutics SA
Schedule 13G ownership disclosure
ADC THERAPEUTICS SA
Common Shares, par value CHF 0.08 per share · CUSIP: H0036K147
Event date: 2025-06-16
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Point72 Asset Management, L.P.
Shares: 7,831,425.00 · Class: 7.0%
- Point72 Capital Advisors, Inc.
Shares: 7,831,425.00 · Class: 7.0%
- Steven A. Cohen
Shares: 7,831,425.00 · Class: 7.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-25-002745
- Form type
- SCHEDULE 13G
- Filer
- ADC Therapeutics SA
- CIK
- CIK 1771910
- Filed
- Jun 17, 2025
- Reporting period
- Jun 16, 2025
- Description
- Schedule 13G beneficial ownership